A Clinical Trial to Evaluate the Safety and Efficacy of ZYH7 Compared to Fenofibrate in Patients With Dyslipidemia

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 109 participants.

Also called NCT01539616

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 109 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01539616
  • CTRI CTRI/2011/11/002147
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
India (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01539616. Randomized; triple masking; primary purpose treatment. Start 2011-11 (registry gives no type); primary completion 2012-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Clinical Trial to Evaluate the Safety and Efficacy of ZYH7 Compared to Fenofibrate in Patients With Dyslipidemia
Condition
Hypertriglyceridemia
Condition
Dyslipidemia
Intervention (Drug)
ZYH7
Intervention (Drug)
ZYH7
Intervention (Drug)
ZYH7
Intervention (Drug)
Fenofibrate
Lead sponsor
Zydus Lifesciences Limited (class: industry)

Record details

Record id
cardio:ct-nct01539616
Content hash
17d33a5b0dd1601e1dcfe729f7b81a0eee46a399415466beedf8cedcf8935182